International Journal of Endocrinology and Metabolism

Published by: Kowsar

Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome

Tomoyuki Kawada 1 , *
Author Information
1 Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan
Article information
  • International Journal of Endocrinology and Metabolism: October 01, 2013, 11 (4); e10418
  • Published Online: October 1, 2013
  • Article Type: Research Article
  • Received: January 23, 2013
  • Revised: April 17, 2013
  • Accepted: April 27, 2013
  • DOI: 10.5812/ijem.10418

To Cite: Kawada T. Insulin-Related Biomarkers to Predict the Risk of Metabolic Syndrome, Int J Endocrinol Metab. 2013 ;11(4):e10418. doi: 10.5812/ijem.10418.

Abstract
Copyright © 2013, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Norris JM, Rich SS. Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2012; 32(9): 2091-6[DOI][PubMed]
  • 2. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012; 32(8): 1771-6[DOI][PubMed]
  • 3. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol. 2010; 9: 87[DOI][PubMed]
  • 4. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010; 13(1): 36-41[DOI][PubMed]
  • 5. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Feskens EJ, Jansen EH, et al. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study). Metabolism. 2011; 60(7): 969-75[DOI][PubMed]
  • 6. Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens. 2011; 24(7): 770-4[DOI][PubMed]
  • 7. Yamasaki T, Tomita K. [Relationship between hyperuricemia and metabolic syndrome]. Nihon Rinsho. 2008; 66(4): 766-70[PubMed]
  • 8. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012; 220(2): 525-31[DOI][PubMed]
  • 9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412-9[PubMed]
  • 10. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008; 294(1)-26[DOI][PubMed]
  • 11. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabetic Medicine. 2002; 19(7): 527-534[DOI]
  • 12. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab. 2004; 89(3): 1481-4[PubMed]
  • 13. DeFronzo Ralph A, Ferrannini Eleuterio, Simonson Donald C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism. 1989; 38(4): 387-395[DOI]
  • 14. Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011; 18(8): 629-39[PubMed]
  • 15. Alberti KGeorge MM, Zimmet Paul, Shaw Jonathan. The metabolic syndrome—a new worldwide definition. The Lancet. 2005; 366(9491): 1059-1062[DOI]
  • 16. Kawada T. Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis. Metabolism. 2010; 59(7): 1044-6[DOI][PubMed]
  • 17. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc Biol. 2008; 28(7): 1385-91[DOI][PubMed]
  • 18. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3): 499-511[PubMed]
  • 19. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Medicine. 1998; 15(7): 539-553[DOI]
  • 20. Li Y, Yatsuya H, Iso H, Tamakoshi K, Toyoshima H. Incidence of metabolic syndrome according to combinations of lifestyle factors among middle-aged Japanese male workers. Prev Med. 2010; 51(2): 118-22[DOI][PubMed]
  • 21. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, et al. Association Between Cigarette Smoking and Metabolic Syndrome: The Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005; 28(8): 2064-2066[DOI]
  • 22. Onat A, Can G, Cicek G, Dogan Y, Kaya H, Gumrukcuoglu HA, et al. Diverging sex-specific long-term effects of cigarette smoking on fasting insulin and glucose levels in non-diabetic people. Clin Biochem. 2012; 45(1-2): 37-42[DOI][PubMed]
  • 23. Tonstad S, Svendsen M. Premature coronary heart disease, cigarette smoking, and the metabolic syndrome. Am J Cardiol. 2005; 96(12): 1681-5[DOI][PubMed]
  • 24. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007; 56(6): 792-8[DOI][PubMed]
  • 25. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005; 112(14): 2130-7[DOI][PubMed]
  • 26. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000; 283(18): 2404-10[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments